Senator Investment Group LP Has $6.95 Million Holdings in Privia Health Group, Inc. (NASDAQ:PRVA)

Senator Investment Group LP cut its position in Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 50.0% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 400,000 shares of the company's stock after selling 400,000 shares during the quarter. Senator Investment Group LP owned approximately 0.34% of Privia Health Group worth $6,952,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Canada Pension Plan Investment Board acquired a new stake in shares of Privia Health Group during the second quarter worth $26,000. Nisa Investment Advisors LLC boosted its stake in Privia Health Group by 107.5% in the second quarter. Nisa Investment Advisors LLC now owns 1,795 shares of the company's stock valued at $31,000 after acquiring an additional 930 shares during the period. Signaturefd LLC boosted its stake in Privia Health Group by 46.3% in the second quarter. Signaturefd LLC now owns 1,978 shares of the company's stock valued at $34,000 after acquiring an additional 626 shares during the period. Park Place Capital Corp boosted its stake in Privia Health Group by 115.4% in the first quarter. Park Place Capital Corp now owns 2,492 shares of the company's stock valued at $49,000 after acquiring an additional 1,335 shares during the period. Finally, Covestor Ltd boosted its position in shares of Privia Health Group by 25.5% during the first quarter. Covestor Ltd now owns 5,292 shares of the company's stock worth $104,000 after buying an additional 1,076 shares during the period. 94.48% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities research analysts recently commented on the company. Evercore ISI dropped their target price on Privia Health Group from $23.00 to $20.00 and set an "outperform" rating on the stock in a report on Tuesday, July 9th. Robert W. Baird boosted their target price on Privia Health Group from $23.00 to $24.00 and gave the stock an "outperform" rating in a report on Monday, August 26th. Finally, Royal Bank of Canada reissued an "outperform" rating and set a $28.00 target price on shares of Privia Health Group in a report on Wednesday, August 14th. Two equities research analysts have rated the stock with a hold rating, twelve have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $24.86.

Insider Activity

In other Privia Health Group news, CEO Parth Mehrotra sold 135,142 shares of Privia Health Group stock in a transaction on Tuesday, September 10th. The shares were sold at an average price of $18.50, for a total transaction of $2,500,127.00. Following the completion of the sale, the chief executive officer now owns 247,771 shares of the company's stock, valued at approximately $4,583,763.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 14.20% of the stock is currently owned by corporate insiders.

Privia Health Group Trading Up 0.7 %

Privia Health Group stock traded up $0.13 during mid-day trading on Monday, hitting $18.21. 711,093 shares of the company's stock were exchanged, compared to its average volume of 878,982. The stock has a market cap of $2.17 billion, a P/E ratio of 121.40, a P/E/G ratio of 4.24 and a beta of 0.77. The stock has a 50 day moving average of $19.43 and a two-hundred day moving average of $18.50. Privia Health Group, Inc. has a 1-year low of $15.92 and a 1-year high of $24.35.

Privia Health Group (NASDAQ:PRVA - Get Free Report) last released its earnings results on Thursday, August 8th. The company reported $0.03 earnings per share for the quarter, missing the consensus estimate of $0.05 by ($0.02). The company had revenue of $422.30 million during the quarter, compared to the consensus estimate of $411.50 million. Privia Health Group had a net margin of 0.88% and a return on equity of 2.42%. The firm's quarterly revenue was up 2.2% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.06 EPS. As a group, research analysts predict that Privia Health Group, Inc. will post 0.16 EPS for the current fiscal year.

Privia Health Group Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.